The Safety of Pimavanserin for Parkinson’s Disease and Efforts to Reduce Antipsychotics for People With Dementia

The Safety of Pimavanserin for Parkinson’s Disease and Efforts to Reduce Antipsychotics for People With Dementia
Am J Psychiatry. 2022 Aug;179(8):519-521. doi: 10.1176/appi.ajp.20220519.NO ABSTRACTPMID:35921393 | DOI:10.1176/appi.ajp.20220519 ... read more
Source: PubMedPublished on 2022-08-03By Lon S Schneider